On May 30, 2018 Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company pioneering the discovery and development of medicines to control the expression of genes, reported that its Chief Executive Officer Nancy Simonian, M.D., will present a corporate overview at upcoming investor conferences (Press release, Syros Pharmaceuticals, MAY 30, 2018, View Source [SID1234526976]). Details are as follows:
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Jefferies 2018 Global Healthcare Conference
Date: Wednesday, June 6
Presentation Time: 3:30 p.m. ET
The JMP Securities Life Sciences Conference
Date: Thursday, June 21
Presentation Time: 2:00 p.m. ET
A live webcast of each presentation will be available on the Investors & Media section of the Syros website at www.syros.com. An archived replay of the webcast will be available for approximately 30 days following each presentation.